Loading...

Bill Skinner & Toby Winchester, Pfizer: The Smaller the Better -- Compound Management Goes 'Nano'

370 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Mar 23, 2012

[Pharma IQ] Bill Skinner and Toby Winchester, Senior Principal Scientists at Pfizer, join Pharma IQ, to discuss the clean up of the Pfizer compound file.

In this exclusive interview, Bill reflects on developments from a data management perspective, while Toby reports on the logistical operations. They discuss the trend towards more compact files and explain what this means for Pfizer. They also discuss implementing the automatic release of compounds for screening -- what it entails and what it means to overall store to screen process. Winchester explains what it means to go 'Nano' in terms of the overall dispensing, screening and/or drug discovery process, and comments on the technologies he expects will shape the future of compound management in the next 2-3 years.

The interview concludes with a discussion on how biologics and chemists can work together to achieve better results, and Skinner and Winchester offer some teamwork tips for the smooth running of a compound management facility.

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...